Zhang YJ - Search Results

1

The SUVmax for (18)F-FDG correlates with molecular subtype and survival of previously untreated metastatic breast cancer.

Zhang J, Jia Z, Zhou M, Ragaz J, Zhang YP, Wang BY, Wang ZH, Hu XC, Zhang YJ. Zhang J, et al. Among authors: zhang yp, zhang yj. Clin Nucl Med. 2013 Apr;38(4):256-62. doi: 10.1097/RLU.0b013e3182816318. Clin Nucl Med. 2013. PMID: 23429396 Clinical Trial.

2

The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.

Zhang J, Jia Z, Ragaz J, Zhang YJ, Zhou M, Zhang YP, Li G, Wang BY, Wang ZH, Hu XC. Zhang J, et al. Among authors: zhang yp, zhang yj. BMC Cancer. 2013 Jan 31;13:42. doi: 10.1186/1471-2407-13-42. BMC Cancer. 2013. PMID: 23368410 Free PMC article.

3

18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.

Zhou M, Wang C, Hu S, Zhang Y, Yao Z, Li J, Guo W, Zhang Y. Zhou M, et al. Nucl Med Commun. 2013 Jul;34(7):694-700. doi: 10.1097/MNM.0b013e328361663a. Nucl Med Commun. 2013. PMID: 23604223

4

Pretreatment ¹⁸F-FDG Uptake Heterogeneity Predicts Treatment Outcome of First-Line Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer.

Gong C, Ma G, Hu X, Zhang Y, Wang Z, Zhang J, Zhao Y, Li Y, Xie Y, Yang Z, Wang B. Gong C, et al. Oncologist. 2018 Oct;23(10):1144-1152. doi: 10.1634/theoncologist.2018-0001. Epub 2018 Aug 6. Oncologist. 2018. PMID: 30082489 Free PMC article.

5

18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer.

Cheng J, Lei L, Xu J, Sun Y, Zhang Y, Wang X, Pan L, Shao Z, Zhang Y, Liu G. Cheng J, et al. J Nucl Med. 2013 Mar;54(3):333-40. doi: 10.2967/jnumed.112.111963. Epub 2013 Feb 11. J Nucl Med. 2013. PMID: 23401605 Free article.

6

Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?

Yang Z, Zhang Y, Shi W, Zhu B, Hu S, Yao Z, Pan H, Hu C, Zhang Y, Li D. Yang Z, et al. Ann Nucl Med. 2014 Jun;28(5):411-6. doi: 10.1007/s12149-014-0831-z. Epub 2014 Mar 8. Ann Nucl Med. 2014. PMID: 24610681

7

Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.

Jiang J, Yang Z, Zhang Y, Xu X, Wang M, Hu S, Yao Z, Pan H, Zhang Y, Li D. Jiang J, et al. Clin Imaging. 2014 Nov-Dec;38(6):797-801. doi: 10.1016/j.clinimag.2014.05.007. Epub 2014 May 21. Clin Imaging. 2014. PMID: 24973077 Clinical Trial.

8

The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy.

Wang C, Guo W, Zhou M, Zhu X, Ji D, Li W, Liu X, Tao Z, Zhang X, Zhang Y, Li J. Wang C, et al. Clin Cancer Res. 2016 Apr 1;22(7):1603-10. doi: 10.1158/1078-0432.CCR-14-3235. Epub 2015 Nov 25. Clin Cancer Res. 2016. PMID: 26607599 Clinical Trial.

9

Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.

Liu C, Zhang Y, Zhang Y, Wang M, Liu R, Liu X, Hu S. Liu C, et al. Nucl Med Commun. 2016 May;37(5):446-52. doi: 10.1097/MNM.0000000000000463. Nucl Med Commun. 2016. PMID: 26657218

10

The Assessment of Estrogen Receptor Status and Its Intratumoral Heterogeneity in Patients With Breast Cancer by Using 18F-Fluoroestradiol PET/CT.

Yang Z, Sun Y, Xu X, Zhang Y, Zhang J, Xue J, Wang M, Yuan H, Hu S, Shi W, Zhu B, Zhang Y. Yang Z, et al. Clin Nucl Med. 2017 Jun;42(6):421-427. doi: 10.1097/RLU.0000000000001587. Clin Nucl Med. 2017. PMID: 28221191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,668 results

Search Page

Filters